Dynocardia

Lowell, MA · Founded 2015 · Privately Held (backing)

Developer of a wearable blood pressure monitoring device designed to accurately and continuously measure blood pressure. Dynocardia is based in Lowell, MA and was founded in 2015. Its last reported valuation was $12.5 million in Jan 2021. It has raised $8.3 million across 4 recorded rounds; the latest was a $1.2 million seed round in Mar 2025.

Last reported valuation
$12.5M
Oct 2026
Priced at
—
Total raised
$8.3M
Last round
Seed Round
Mar 2025

Who backs Dynocardia?

11 investors
InvestorType
US National Science FoundationOther
National Institutes of HealthOther
NextCorps LuminateOther
Mayo Clinic PlatformOther
3DEXPERIENCE Lab—
Garage+—
MassMEDIC—
Massachusetts Technology Collaborative—
Massachusetts eHealth Institute—
Small Business Innovation Research and Small Business Technology Transfer Programs—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Dynocardia investors

11 investors are on record for Dynocardia, including US National Science Foundation, National Institutes of Health, NextCorps Luminate and Mayo Clinic Platform. The seed round in Mar 2025 drew 20 investors.

Free account
More of Dynocardia with a free account
  • ·The complete investor list: 11 names
  • ·Watch Dynocardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Dynocardia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View